Authors: SCHELLHAMMER PF BLOCK NL SHARIFI R SOLOWAY MS PATTERSON AL VOGELZANG NJ SAROSDY MF FURR B CAPLAN R KOLVENBAG GJCM

Citation: Pf. Schellhammer et al., ESTIMATED POTENCY OF CASODEX - A PROBLEMATIC DESIGN - REPLY, Urology, 50(2), 1997, pp. 311-313

Authors: SCHELLHAMMER PF VENNER P HAAS GP SMALL EJ NIEH PT SEABAUGH DR PATTERSON AL KLEIN E WAJSMAN Z FURR B CHEN YS KOLVENBAG GJCM

Citation: Pf. Schellhammer et al., PROSTATE-SPECIFIC ANTIGEN DECREASES AFTER WITHDRAWAL OF ANTIANDROGEN THERAPY WITH BICALUTAMIDE OR FLUTAMIDE IN PATIENTS RECEIVING COMBINED ANDROGEN BLOCKADE, The Journal of urology, 157(5), 1997, pp. 1731-1735

Authors: MALKOWICZ SB FURR B ANDRIOLE GL BLACKLEDGE G DENIS L BLOCK N MONTIE JE SCHELLHAMMER PF SCHMIDT J LAVINE R OESTERLING JE

Citation: Sb. Malkowicz et al., THE BASIC SCIENCE OF BICALUTAMIDE AS A ONCE-DAILY ORAL ANTIANDROGEN -DISCUSSION, Urology, 47(1A), 1996, pp. 29-32

Authors: ANDRIOLE GL DENIS L BLACKLEDGE G SCHMIDT J SAGALOWSKY A IVERSEN P SOLOWAY M FURR B BLOCK N BANERJEE T YOUNG J KOLVENBAG GCM OESTERLING JE NIEH PTC MONTIE JE SCHELLHAMMER PF BALES GT KLEIN EA BROSMAN S

Citation: Gl. Andriole et al., CLINICAL-TRIALS OF BICALUTAMIDE AS MONOTHERAPY FOR PROSTATE-CANCER - DISCUSSION, Urology, 47(1A), 1996, pp. 48-53

Authors: RICHIE JP SCHELLHAMMER PF SCHER H HAAS G PATTERSON K SAGALOWSKY A KOLVENBAG GJCM KENNEALEY G IVERSEN P BROSMAN S KLEIN EA FURR B BLOCK N DENIS L SCHMIDT J SOLOWAY M OESTERLING JE YOUNG J

Citation: Jp. Richie et al., CLINICAL-DATA ON THE ROLE OF BICALUTAMIDE IN METASTATIC PROSTATE-CANCER - DISCUSSION, Urology, 47(1A), 1996, pp. 80-84